[go: up one dir, main page]

EE200200209A - Otsese pressimisega valmistatud polümeerne tabletisüdamik - Google Patents

Otsese pressimisega valmistatud polümeerne tabletisüdamik

Info

Publication number
EE200200209A
EE200200209A EEP200200209A EEP200200209A EE200200209A EE 200200209 A EE200200209 A EE 200200209A EE P200200209 A EEP200200209 A EE P200200209A EE P200200209 A EEP200200209 A EE P200200209A EE 200200209 A EE200200209 A EE 200200209A
Authority
EE
Estonia
Prior art keywords
direct compression
tablet core
polymer tablet
compression polymer
core
Prior art date
Application number
EEP200200209A
Other languages
English (en)
Estonian (et)
Inventor
Tyler Joseph
S. Petersen John
Original Assignee
Geltex Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geltex Pharmaceuticals, Inc. filed Critical Geltex Pharmaceuticals, Inc.
Publication of EE200200209A publication Critical patent/EE200200209A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EEP200200209A 1999-10-19 2000-10-13 Otsese pressimisega valmistatud polümeerne tabletisüdamik EE200200209A (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16025899P 1999-10-19 1999-10-19
US17422700P 2000-01-03 2000-01-03
PCT/US2000/028548 WO2001028527A2 (en) 1999-10-19 2000-10-13 Direct compression polymer tablet core

Publications (1)

Publication Number Publication Date
EE200200209A true EE200200209A (et) 2003-06-16

Family

ID=26856737

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200209A EE200200209A (et) 1999-10-19 2000-10-13 Otsese pressimisega valmistatud polümeerne tabletisüdamik

Country Status (29)

Country Link
EP (1) EP1239837B1 (zh)
JP (4) JP4942271B2 (zh)
KR (1) KR100794427B1 (zh)
CN (1) CN1202812C (zh)
AR (1) AR026067A1 (zh)
AT (1) ATE286386T1 (zh)
AU (1) AU778262B2 (zh)
BG (1) BG106626A (zh)
BR (1) BRPI0015061B8 (zh)
CA (1) CA2387915C (zh)
CZ (1) CZ20021344A3 (zh)
DE (1) DE60017285T2 (zh)
EA (1) EA200200387A1 (zh)
EE (1) EE200200209A (zh)
ES (1) ES2235969T3 (zh)
HK (1) HK1049451B (zh)
HU (1) HUP0203334A2 (zh)
IL (1) IL149146A0 (zh)
IS (1) IS6343A (zh)
MX (1) MXPA02003684A (zh)
MY (1) MY125495A (zh)
NO (1) NO20021827L (zh)
NZ (1) NZ518334A (zh)
PL (1) PL364888A1 (zh)
PT (1) PT1239837E (zh)
SK (1) SK5412002A3 (zh)
TR (1) TR200201087T2 (zh)
TW (1) TWI225413B (zh)
WO (1) WO2001028527A2 (zh)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE200200209A (et) * 1999-10-19 2003-06-16 Geltex Pharmaceuticals, Inc. Otsese pressimisega valmistatud polümeerne tabletisüdamik
US7767768B2 (en) 2003-11-03 2010-08-03 Ilypsa, Inc. Crosslinked amine polymers
US7459502B2 (en) 2003-11-03 2008-12-02 Ilypsa, Inc. Pharmaceutical compositions comprising crosslinked polyamine polymers
US7335795B2 (en) 2004-03-22 2008-02-26 Ilypsa, Inc. Crosslinked amine polymers
US7608674B2 (en) 2003-11-03 2009-10-27 Ilypsa, Inc. Pharmaceutical compositions comprising cross-linked small molecule amine polymers
US7385012B2 (en) 2003-11-03 2008-06-10 Ilypsa, Inc. Polyamine polymers
US7449605B2 (en) 2003-11-03 2008-11-11 Ilypsa, Inc. Crosslinked amine polymers
AU2004311849B2 (en) * 2003-12-31 2009-04-02 Genzyme Corporation Enteric coated aliphatic amine polymer bile acid sequestrants
EP2184059B1 (en) 2004-03-30 2012-06-27 Relypsa, Inc. Potassium-binding polymers for use in a therapeutic or prophylactic method for treating hyperkalemia
AU2012200480B2 (en) * 2004-11-01 2014-10-16 Genzyme Corporation "Aliphatic amine polymer salts for tableting"
US7985418B2 (en) * 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
MX2007011153A (es) * 2005-03-17 2007-12-12 Amgen Inc Metodos para reducir la calcificacion.
JP2009507019A (ja) 2005-09-02 2009-02-19 ジェンザイム・コーポレーション リン酸塩を除去する方法およびそれに使用される重合体
CN103027896B (zh) * 2005-09-15 2016-01-20 基酶有限公司 胺聚合物的小袋制剂
EP2064252A2 (en) * 2006-09-01 2009-06-03 Usv Limited Process for the preparation of sevelamer hydrochloride and formulation thereof
EP2066293A2 (en) 2006-09-29 2009-06-10 Genzyme Corporation Amide dendrimer compositions
US8163799B2 (en) 2006-12-14 2012-04-24 Genzyme Corporation Amido-amine polymer compositions
WO2009034540A1 (en) * 2007-09-11 2009-03-19 Ranbaxy Laboratories Limited Pharmaceutical composition of sevelamer
DE102008030046A1 (de) 2008-06-25 2009-12-31 Ratiopharm Gmbh Kompaktiertes Polyallylamin-Polymer
RU2011112694A (ru) 2008-09-02 2012-10-10 Юсв Лимитед (In) Сшитые полимеры
US20100330175A1 (en) * 2009-06-24 2010-12-30 Jobdevairakkam Christopher N Cross-linked polyallylamine tablet core
ES2350999B1 (es) * 2009-06-26 2011-12-07 Combino Pharm, S.L. Nueva composición farmacéutica comprendiendo hidrocloruro de poli (alilamin-co-n,n'-dialil-1,3-diamino-2-hidroxi propano).
WO2010149794A2 (en) 2009-06-26 2010-12-29 Combino Pharm, S.L. Novel pharmaceutical composition comprising poly (allylamin-co-n,n'-diallyl- 1,3-diamino-2-hydroxypropane)
EP2490675B1 (en) * 2009-10-22 2019-01-23 Synthon B.V. Pharmaceutical compositions of sevelamer
EP2545907A1 (en) 2011-07-15 2013-01-16 Combino Pharm, S.L. Aqueous wet granulation process for cross-linked polyallylamine polymers
WO2013183497A1 (ja) * 2012-06-05 2013-12-12 武田薬品工業株式会社 有核錠
CN102908325B (zh) * 2012-11-12 2014-07-30 南京生命能科技开发有限公司 一种碳酸司维拉姆药用片剂组合物及其制备方法
CN107412166B (zh) * 2017-08-08 2020-03-24 同济大学 一种纳米复合吸附磷材料及其制备与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL169045B1 (pl) * 1991-07-03 1996-05-31 Upjohn Co Sposób wytwarzania tabletki farmaceutycznej do leczenia lub zapobiegania hipercholesterolemii PL
US5496545A (en) * 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
JP3389493B2 (ja) * 1997-04-04 2003-03-24 中外製薬株式会社 リン酸結合性ポリマー製剤
TW592727B (en) * 1997-04-04 2004-06-21 Chugai Pharmaceutical Co Ltd Phosphate-binding polymer preparations
US6083497A (en) * 1997-11-05 2000-07-04 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers
TW568788B (en) * 1998-10-12 2004-01-01 Chugai Pharmaceutical Co Ltd Polymer combining with phosphoric acid and preparation containing the same
EE200200209A (et) * 1999-10-19 2003-06-16 Geltex Pharmaceuticals, Inc. Otsese pressimisega valmistatud polümeerne tabletisüdamik

Also Published As

Publication number Publication date
ATE286386T1 (de) 2005-01-15
NO20021827L (no) 2002-05-29
CN1202812C (zh) 2005-05-25
HUP0203334A2 (hu) 2003-02-28
AU778262B2 (en) 2004-11-25
JP2016000753A (ja) 2016-01-07
PT1239837E (pt) 2005-05-31
CZ20021344A3 (cs) 2002-08-14
JP5583110B2 (ja) 2014-09-03
DE60017285T2 (de) 2005-12-08
PL364888A1 (en) 2004-12-27
EA200200387A1 (ru) 2002-10-31
AU1088701A (en) 2001-04-30
CA2387915C (en) 2007-04-17
NZ518334A (en) 2003-08-29
MXPA02003684A (es) 2002-08-30
WO2001028527A3 (en) 2002-01-03
AR026067A1 (es) 2002-12-26
CA2387915A1 (en) 2001-04-26
EP1239837B1 (en) 2005-01-05
JP2012067132A (ja) 2012-04-05
BRPI0015061B8 (pt) 2021-05-25
NO20021827D0 (no) 2002-04-18
HK1049451A1 (zh) 2003-05-16
EP1239837A2 (en) 2002-09-18
SK5412002A3 (en) 2002-09-10
WO2001028527A2 (en) 2001-04-26
JP5903111B2 (ja) 2016-04-13
KR20020059629A (ko) 2002-07-13
ES2235969T3 (es) 2005-07-16
IL149146A0 (en) 2002-11-10
KR100794427B1 (ko) 2008-01-16
JP2014065749A (ja) 2014-04-17
DE60017285D1 (de) 2005-02-10
BG106626A (bg) 2003-03-31
IS6343A (is) 2002-04-15
CN1382041A (zh) 2002-11-27
HK1049451B (zh) 2005-12-16
TR200201087T2 (tr) 2002-08-21
TWI225413B (en) 2004-12-21
JP2003512317A (ja) 2003-04-02
MY125495A (en) 2006-08-30
BRPI0015061B1 (pt) 2016-03-22
BR0015061A (pt) 2002-07-23
JP4942271B2 (ja) 2012-05-30

Similar Documents

Publication Publication Date Title
NO20021827D0 (no) Direkte kompresjons-polymer tablettkjerne
DE60042164D1 (de) Kompaktes nadelschutzschild
DE60044622D1 (de) Polymerisationsverfahren
NO2008005I1 (no) Trabectedin
DE60025897D1 (de) Polymerbindemittel
DE60006609D1 (de) Polyelektrolytgel
DE60039789D1 (de) Polymerzelle
DE60017202D1 (de) Polymerisationsverfahren
FI991029L (fi) Puristin
DE50009614D1 (de) Pressenpartie
DE50006381D1 (de) Pressenpartie
DE50003528D1 (de) Formkörper
NO991364D0 (no) Komprimeringsmaskin
DE69936634D1 (de) Medizinischer Kompressionsartikel
DE50013385D1 (de) Entgasungseinrichtung
DK1239837T3 (da) Polymertabletkerne fremstillet ved direkte kompression
DE60022732T2 (de) Audiokodierung
DE50014234D1 (de) Pressanordnung
NO991359D0 (no) Tablettdispenser
ZA200202772B (en) Direct compression polymer tablet core.
DE50000416D1 (de) Totpunktschalter
FI4077U1 (fi) Pellettipuristin
DE50010026D1 (de) Presseanordnung
FIU990201U0 (fi) Pakkausalusta
FI990823L (fi) Puristin